GMT Capital Corp

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1106191 ATLANTA, GA

Position in JAZZ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$109,279,895

-$558,155 QoQ

Shares Held

453,500

-21.9% QoQ

Ownership

0.699%

of shares outstanding

% of Portfolio

5.70%

of 13F equity value

Holder Rank

#31

of 640 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GMT Capital Corp holds $119,129,833 across 5 Biotechnology names. JAZZ ranks #1 (91.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc This page	453,500	$109,279,895
2	OCGN	Ocugen, Inc.	3,505,398	$5,363,258
3	PGEN	Precigen, Inc.	668,830	$3,812,331
4	FLNA	Filana Therapeutics, Inc.	450,100	$535,619
5	INO	Inovio Pharmaceuticals, Inc.	126,119	$138,730

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$109,279,895	453,500	-21.9%	Shares	Sole	2026-08-14
2026-03-31	$109,838,050	581,000	-9.0%	Shares	Sole	2026-05-15
2025-12-31	$108,545,000	638,500	-19.5%	Shares	Sole	2026-02-13
2025-09-30	$104,491,040	792,800	+3.2%	Shares	Sole	2025-11-14
2025-06-30	$81,542,608	768,400	+14.2%	Shares	Sole	2025-08-14
2025-03-31	$83,540,535	672,900	+32.3%	Shares	Sole	2025-05-15
2024-12-31	$62,658,720	508,800	+140.0%	Shares	Sole	2025-02-14
2024-09-30	$23,618,920	212,000	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.